1. Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis.
Neurology 2015;84:2247-2257.
3. Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Neurology 2016;87:1329-1336.
4. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.
Lancet Neurol 2010;9:689-701.
5. Gattringer T, Pinter D, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease.
Neurology 2017;89:2108-2114.
6. Traenka C, Disanto G, Seiffge DJ, Gensicke H, Hert L, Grond-Ginsbach C, et al. Serum neurofilament light chain levels are associated with clinical characteristics and outcome in patients with cervical artery dissection.
Cerebrovasc Dis 2015;40:222-227.
7. Jonsson M, Zetterberg H, van Straaten E, Lind K, Syversen S, Edman A, et al. Cerebrospinal fluid biomarkers of white matter lesions: cross-sectional results from the LADIS study.
Eur J Neurol 2010;17:377-382.
8. Duering M, Csanadi E, Gesierich B, Jouvent E, Hervé D, Seiler S, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease.
Brain 2013;136(Pt 9):2717-2726.
10. Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinimetric and clinical considerations.
Clin Interv Aging 2013;8:201-211.
11. Zieren N, Duering M, Peters N, Reyes S, Jouvent E, Hervé D, et al. Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Neurobiol Aging 2013;34:400-407.
12. Charlton RA, Morris RG, Nitkunan A, Markus HS. The cognitive profiles of CADASIL and sporadic small vessel disease.
Neurology 2006;66:1523-1526.
13. Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education.
Arch Clin Neuropsychol 2004;19:203-214.
14. Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Assessment of information processing in working memory in applied settings: the paper and pencil memory scanning test.
Psychol Med 2007;37:1335-1344.
15. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. The Concept Shifting Test: adult normative data.
Psychol Assess 2006;18:424-432.
16. Norgren N, Karlsson JE, Rosengren L, Stigbrand T. Monoclonal antibodies selective for low molecular weight neurofilaments.
Hybrid Hybridomics 2002;21:53-59.
17. Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, et al. A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.
Ann Neurol 2016;80:581-592.
18. Wollenweber FA, Baykara E, Zedde M, Gesierich B, Achmüller M, Jouvent E, et al. Cortical superficial siderosis in different types of cerebral small vessel disease.
Stroke 2017;48:1404-1407.
19. Behrens TE, Berg HJ, Jbabdi S, Rushworth MF, Woolrich MW. Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?
Neuroimage 2007;34:144-155.
20. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging.
Magn Reson Med 2003;50:1077-1088.
21. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.
Neuroimage 2006;31:1487-1505.
22. R Core Team. A Language and Environment for Statistical Computing Vienna, AU: R Foundation for Statistical Computing; 2016.
23. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R.
Bioinformatics 2005;21:3940-3941.
24. Williams DA. Generalized linear model diagnostics using the deviance and single case deletions.
J R Stat Soc Ser C Appl Stat 1987;36:181-191.
27. Kuhle J, Plattner K, Bestwick JP, Lindberg RL, Ramagopalan SV, Norgren N, et al. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Mult Scler 2013;19:1597-1603.
28. Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
PLoS One 2013;8:e75091.
29. Benjamin P, Zeestraten E, Lambert C, Ster IC, Williams OA, Lawrence AJ, et al. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials.
J Cereb Blood Flow Metab 2016;36:228-240.
30. de Laat KF, van Norden AG, Gons RA, van Oudheusden LJ, van Uden IW, Norris DG, et al. Diffusion tensor imaging and gait in elderly persons with cerebral small vessel disease.
Stroke 2011;42:373-379.
31. Voineskos AN, Rajji TK, Lobaugh NJ, Miranda D, Shenton ME, Kennedy JL, et al. Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study.
Neurobiol Aging 2012;33:21-34.
32. Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
Lancet Neurol 2014;13:1177-1185.
33. Haller S, Monsch AU, Richiardi J, Barkhof F, Kressig RW, Radue EW. Head motion parameters in fMRI differ between patients with mild cognitive impairment and Alzheimer disease versus elderly control subjects.
Brain Topogr 2014;27:801-807.
34. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
Lancet Neurol 2013;12:822-838.
35. De Guio F, Jouvent E, Biessels GJ, Black SE, Brayne C, Chen C, et al. Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.
J Cereb Blood Flow Metab 2016;36:1319-1337.
36. Nagai M, Hoshide S, Kario K. Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients.
Am J Hypertens 2012;25:1088-1094.
37. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study.
Neurology 2012;78:720-727.
38. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study.
Circulation 2005;112:900-905.
39. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study.
Stroke 2005;36:1410-1414.
40. Vilar-Bergua A, Riba-Llena I, Penalba A, Cruz LM, Jiménez-Balado J, Montaner J, et al. N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease.
Neurology 2016;87:2533-2539.
41. Wiseman SJ, Doubal FN, Chappell FM, Valdés-Hernández MC, Wang X, Rumley A, et al. Plasma biomarkers of inflammation, endothelial function and hemostasis in cerebral small vessel disease.
Cerebrovasc Dis 2015;40:157-164.
42. Schmidt R, Schmidt H, Pichler M, Enzinger C, Petrovic K, Niederkorn K, et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study.
Stroke 2006;37:2910-2916.
43. Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, et al. Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
J Neurol Neurosurg Psychiatry 2016;87:126-129.
44. Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, et al. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Mult Scler 2016;22:1550-1559.
45. Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Clin Chem Lab Med 2016;54:1655-1661.